EDGAR Filing Documents for 0001654954-19-008564

Form 8-K - Current report:

SEC Accession No. 0001654954-19-008564

Filing Date

2019-07-29

Accepted

2019-07-29 08:40:30

Documents

Period of Report

2019-07-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ndra_8k.htm	8-K	48052
2	FORM OF CONVERTIBLE PROMISSORY NOTE	ndra_ex4-1.htm	EX-4.1	104084
3	FORM OF WARRANT.	ndra_ex4-2.htm	EX-4.2	87791
4	FORM OF SECURITIES PURCHASE AGREEMENT DATED JULY 26, 2019.	ndra_ex10-1.htm	EX-10.1	215405
5	FORM OF REGISTRATION RIGHTS AGREEMENT DATED JULY 26, 2019.	ndra_ex10-2.htm	EX-10.2	86615
6	FORM OF SECURITY AGREEMENT DATED JULY 26, 2019.	ndra_ex10-3.htm	EX-10.3	148402
7	PRESS RELEASE DATED JULY 29, 2019 ISSUED BY THE COMPANY, FURNISHED HEREWITH.	ndra_ex99-1.htm	EX-99.1	15945
8	IMAGE	ndra_ex99-1000.jpg	GRAPHIC	6836
	Complete submission text file	0001654954-19-008564.txt		717323

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105

Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468

ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)